Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129005) titled 'Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids' on Aug. 3.

Study Type: Observational

Primary Sponsor: Tongji Hospital

Condition: Uterine Fibroid Uterine Sarcoma Diagnose Disease AI (Artificial Intelligence)

Intervention: Other: No intervention (observational study)

Recruitment Status: Recruiting

Date of First Enrollment: January 1, 2025

Target Sample Size: 520

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07129005

Published by HT Digital Content Services with permission from Health Daily Digest....